Katie Worthington
Acute Care · New York, NYNPI 1770950727
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $18,331 of the $24,758 with a category attached, or 74.0%. Edwards Lifesciences accounts for 60.8% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $9,021, 2.4 times the $3,780 reported in 2021. Among acute care clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 540 payments — averaging $45.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$15K
- Medtronic$7K
- Abbott$1K
- AOP Health US, LLC$510
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$373
- Cardiva Medical, Inc.$222
- plus $792 from 11 others
What the payments were for
- Consulting fees$2,50010%
- Travel & lodging$3,91816%
- Food & beverage$18,33174%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 269 | $15,065 |
| Medtronic | 168 | $6,534 |
| Abbott | 41 | $1,263 |
| AOP Health US, LLC | 1 | $510 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $373 |
| Cardiva Medical, Inc. | 10 | $222 |
| Pfizer | 12 | $202 |
| Boston Scientific | 7 | $162 |
| Abiomed | 1 | $146 |
| W. L. Gore & Associates, Inc. | 7 | $119 |
| AstraZeneca | 3 | $41 |
| Irhythm Technologies, Inc. | 1 | $34 |
| Philips North America LLC | 1 | $26 |
| Novartis | 1 | $21 |
| Johnson & Johnson | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Haemonetics Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$2,006
- Rapiblyk$1,019
- CoreValve Evolut$961
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$737
- SAPIEN 3 Ultra RESILIA$466
- CARDIOMEMS$143
- SYMPLICITY G3$141
- LifeVest$120
How this compares
$24,758 in reported general payments places this provider in the 95th percentile of 980 acute care providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in New York
- Daniel VerinaNew York$464K
- Loveth AdenugaNew York$20K
- Katherine DukeNew York$18K
- Julie Anne RoldanNew York$10K
- Lauren Dela CruzNew York$9K
- Kristen DonchezNew York$8K
- Tracy Valerie BertizNew York$7K
- Jennifer UllmanNew York$7K
- Sara-Jane DakroubNew York$6K
- Kathryn CiccoliniNew York$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.